Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The methyltransferase-like proteins as core regulators of nucleic acid modifications and post-translation modification of proteins in disease pathogenesis and therapeutic implications. | Biomark Res | 2025 | 41194259 | PubTator, text mining | PubMed |
| m6A-mediated upregulation of miR-3690 drives HNSCC progression by regulating nuclear-cytoplasmic signaling pathway. | Cell Mol Life Sci | 2025 | 41165830 | PubTator, text mining | PubMed |
| METTL14 in tumor immunity: epitranscriptomic regulation and therapeutic potential. | Front Immunol | 2025 | 41164187 | PubTator, text mining | PubMed |
| Decreased ALKBH5 in neutrophil correlates with disease activity in rheumatoid arthritis and ALKBH5 modulates neutrophil autophagy. | Sci Rep | 2025 | 41162497 | PubTator, text mining | PubMed |
| Adipose m6A reader YTHDF2 promotes obesity, insulin resistance, and liver steatosis by suppressing β-adrenergic signaling and lipolysis. | Cell Rep | 2025 | 41100256 | PubTator, text mining | PubMed |
| Single-base m6A epitranscriptomics reveals novel HIV-1 host interaction targets in primary CD4+ T cells. | J Virol | 2025 | 41085277 | PubTator, text mining | PubMed |
| The Role of m6A Modification in Regulating MSC Differentiation and Immunomodulation: Implications for Regenerative Medicine and Therapeutic Applications. | Front Biosci (Landmark Ed) | 2025 | 41074424 | PubTator, text mining | PubMed |
| ERβ/circAHNAK Axis Inhibits USP10-FMR1 Deubiquitination to Prevent m⁶A-Mediated ADAM17 Decay and Promote Angiogenesis in Clear Cell Renal Cell Carcinoma. | Adv Sci (Weinh) | 2025 | 41058008 | PubTator, text mining | PubMed |
| Arginine methylation-dependent METTL14-SMN interaction regulates RNA m6A homeostasis. | EMBO Rep | 2025 | 41053315 | PubTator, text mining | PubMed |
| Differential m6A methylation landscapes in breast and leg muscles of Zhijin white geese: Epigenetic insights into muscle development. | Genomics | 2025 | 41043724 | PubTator, text mining | PubMed |
| Local translation under epitranscriptomic control. | Trends Neurosci | 2025 | 41033857 | PubTator, text mining | PubMed |
| The m6A demethylase METTL14 inhibits the development and progression of lung squamous cell carcinoma by upregulating CD19+ IgD- CD38dim. | Medicine (Baltimore) | 2025 | 41029126 | PubTator, text mining | PubMed |
| METTL14 knockdown augmented the polarization of M2-like macrophages to promote acute myeloid leukemia progression. | Hum Cell | 2025 | 41026373 | PubTator, text mining | PubMed |
| Identification of prognostic biomarkers for hepatocellular carcinoma based on the m6A RNA modification. | Int J Immunopathol Pharmacol | 2025 | 41013996 | PubTator, text mining | PubMed |
| Structural and Functional Studies on Key Epigenetic Regulators in Asthma. | Biomolecules | 2025 | 41008562 | PubTator, text mining | PubMed |
| Altered Expression of m6A-Associated Genes Is Linked with Poor Prognosis in Pediatric Acute Myeloid Leukemia Patients. | Biomolecules | 2025 | 41008545 | PubTator, text mining | PubMed |
| Targeted and epigenetic therapies for acute myeloid leukemia treatment. | Discov Oncol | 2025 | 41003912 | PubTator, text mining | PubMed |
| Molecular mechanisms and crop improvement potential of RNA N6-methyladenosine in plants. | aBIOTECH | 2025 | 40994448 | PubTator, text mining | PubMed |
| Regulatory roles of RNA modifications in plant development and fruit ripening. | aBIOTECH | 2025 | 40994446 | PubTator, text mining | PubMed |
| N6-methyladenosine-modified ACSM3 mitigates lipid accumulation and suppresses tumor progression in ccRCC via GATA5/HMGCS2 axis and mTORC1 signaling. | Int J Biol Macromol | 2025 | 40992469 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=12